Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
出版年份 2018 全文链接
标题
Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
作者
关键词
Multiple myeloma, Wnt signaling, β-catenin, Osteolytic bone disease, Drug resistance, Targeted therapy
出版物
Journal of Hematology & Oncology
Volume 11, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-05-18
DOI
10.1186/s13045-018-0615-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Wnt signaling in cervical cancer?
- (2018) Min Yang et al. Journal of Cancer
- Wnt Signalling in Gastrointestinal Epithelial Stem Cells
- (2018) Dustin Flanagan et al. Genes
- Evidence of the Role of R-Spondin 1 and Its Receptor Lgr4 in the Transmission of Mechanical Stimuli to Biological Signals for Bone Formation
- (2017) Gui-Xun Shi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma
- (2017) Ioanna Savvidou et al. MOLECULAR CANCER THERAPEUTICS
- WNT signalling in prostate cancer
- (2017) Virginia Murillo-Garzón et al. Nature Reviews Urology
- Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
- (2017) Matthew McCord et al. Frontiers in Cellular Neuroscience
- Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
- (2017) Wei Xu et al. Scientific Reports
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Multiple myeloma in the marrow: pathogenesis and treatments
- (2016) Heather Fairfield et al. Annals of the New York Academy of Sciences
- New approaches to targeting the bone marrow microenvironment in multiple myeloma
- (2016) Sarah Gooding et al. CURRENT OPINION IN PHARMACOLOGY
- Fatty acylation of Wnt proteins
- (2016) Aaron H Nile et al. Nature Chemical Biology
- Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease
- (2016) H van Andel et al. ONCOGENE
- Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins
- (2016) Harmen van Andel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Making, Exporting, and Modulating Wnts
- (2016) Paul F. Langton et al. TRENDS IN CELL BIOLOGY
- The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines
- (2016) Daniela Kovacs et al. Oncotarget
- Microenvironment drug resistance in multiple myeloma: emerging new players
- (2016) Lucia Di Marzo et al. Oncotarget
- Mammary Development and Breast Cancer: A Wnt Perspective
- (2016) Qing Yu et al. Cancers
- Molecular pathogenesis of multiple myeloma
- (2015) Yusuke Furukawa et al. International Journal of Clinical Oncology
- Multiple myeloma
- (2015) Christoph Röllig et al. LANCET
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition
- (2015) B Madan et al. ONCOGENE
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
- (2015) Phuong N. Le et al. PHARMACOLOGY & THERAPEUTICS
- Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway
- (2015) Ri Youn Kim et al. TISSUE ENGINEERING PART A
- The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling
- (2015) Neil Rajan et al. Oncotarget
- A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events
- (2014) Swaminathan P. Iyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway
- (2014) Jian-Jun Zhao et al. CANCER RESEARCH
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength
- (2014) W. de Lau et al. GENES & DEVELOPMENT
- Role of -Catenin in B Cell Development and Function
- (2014) Q. Yu et al. JOURNAL OF IMMUNOLOGY
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis
- (2013) Y. Zhang et al. CANCER RESEARCH
- Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma
- (2013) Y. Hua et al. CLINICAL CANCER RESEARCH
- The Osteocyte: An Endocrine Cell … and More
- (2013) Sarah L. Dallas et al. ENDOCRINE REVIEWS
- Wnt signaling in leukemias and myeloma: T-cell factors are in control
- (2013) Machteld M Tiemessen et al. Future Oncology
- Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications
- (2013) C C Bjorklund et al. LEUKEMIA
- WNT signaling in bone homeostasis and disease: from human mutations to treatments
- (2013) Roland Baron et al. NATURE MEDICINE
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
- (2013) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
- (2012) Ana Chocarro-Calvo et al. MOLECULAR CELL
- Active Wnt proteins are secreted on exosomes
- (2012) Julia Christina Gross et al. NATURE CELL BIOLOGY
- Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
- (2012) Kazuhiro Maeda et al. NATURE MEDICINE
- Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma
- (2012) Kinga A. Kocemba et al. PLoS One
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis of Wnt Recognition by Frizzled
- (2012) C. Y. Janda et al. SCIENCE
- WNT secretion and signalling in human disease
- (2012) Patrick Herr et al. TRENDS IN MOLECULAR MEDICINE
- CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt
- (2012) Jae Hyang Lim et al. Nature Communications
- Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir
- (2011) Francisco Santiago et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SUMOylation in carcinogenesis
- (2011) Kira Bettermann et al. CANCER LETTERS
- Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development
- (2011) T C Luis et al. LEUKEMIA
- Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by -Catenin
- (2011) W. Wei et al. MOLECULAR AND CELLULAR BIOLOGY
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Striking the target in Wnt-y conditions: Intervening in Wnt signaling during cancer progression
- (2010) Tura C. Camilli et al. BIOCHEMICAL PHARMACOLOGY
- Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling
- (2010) T. C. Luis et al. BLOOD
- Tumor–host cell interactions in the bone disease of myeloma
- (2010) Jessica A. Fowler et al. BONE
- Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and β-catenin/Wnt pathways
- (2010) Sara Previdi et al. EUROPEAN JOURNAL OF CANCER
- Evidence of a Role for Activation of Wnt/β-Catenin Signaling in the Resistance of Plasma Cells to Lenalidomide
- (2010) Chad C. Bjorklund et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of the Tumor Suppressor CYLD Enhances Wnt/β-Catenin Signaling through K63-Linked Ubiquitination of Dvl
- (2010) Daniele V.F. Tauriello et al. MOLECULAR CELL
- Aurora kinase A is a target of Wnt/ -catenin involved in multiple myeloma disease progression
- (2009) J. Dutta-Simmons et al. BLOOD
- The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
- (2009) J. J. Driscoll et al. BLOOD
- Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma
- (2009) R. M. Reijmers et al. BLOOD
- BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells
- (2009) M. Mani et al. CANCER RESEARCH
- T Lymphocytes Amplify the Anabolic Activity of Parathyroid Hormone through Wnt10b Signaling
- (2009) Masakazu Terauchi et al. Cell Metabolism
- -Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model
- (2009) E. Ashihara et al. CLINICAL CANCER RESEARCH
- Acquisition of SOX transcription factor specificity through protein–protein interaction, modulation of Wnt signalling and post-translational modification
- (2009) Pascal Bernard et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Role of decorin in the antimyeloma effects of osteoblasts
- (2008) X. Li et al. BLOOD
- Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth
- (2008) Y.-W. Qiang et al. BLOOD
- The pathogenesis of the bone disease of multiple myeloma
- (2008) Claire M. Edwards et al. BONE
- Osteocytes, mechanosensing and Wnt signaling
- (2008) Lynda F. Bonewald et al. BONE
- Wnt signaling controls the fate of mesenchymal stem cells
- (2008) Ling Ling et al. GENE
- Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
- (2008) L. Pederson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started